Patient-prosthesis mismatch (PPM) occurs when an implanted prosthetic valve is too small for the patient; severe PPM is defined as an indexed effective orifice area (iEOA) <0.65 cm 2 /m 2 following ...
The U.S. Food and Drug Administration (FDA) has approved the EVOQUE tricuspid valve replacement system for the treatment of tricuspid regurgitation (TR). According to an Edwards press release, “it is ...
The U.S. Food and Drug Administration has approved on April 2 the Abbott TriClip™, a transcatheter edge-to-edge repair (TEER) system specifically designed for the treatment of tricuspid regurgitation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results